🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Cathie Wood's ARK sheds Robinhood stock, adds to Amazon and Coinbase

Published 09-10-2024, 05:40 am
© Reuters.
AMZN
-
COIN
-
HOOD
-

Cathie Wood's ARK ETF published their daily trades for Tuesday, October 8th, 2024, revealing a mix of significant buy and sell actions across various sectors. The most substantial move of the day was the sale of Robinhood Markets Inc (NASDAQ:HOOD) shares, with a total of 1,421,431 shares offloaded across three ARK funds, amounting to a considerable $33,147,770. This move marks a notable reduction in ARK's position in the fintech company, with the ARKK ETF leading the sell-off.

On the acquisition front, ARK displayed continued confidence in the tech sector, purchasing 76,505 shares of Amazon.com Inc (NASDAQ:AMZN) for $13,832,104 through its ARKK ETF. This buy aligns with a recent trend as ARK has steadily increased its stake in the e-commerce giant.

Another significant investment included Coinbase Global Inc (NASDAQ:COIN), with ARK adding 12,994 shares through its ARKF ETF, totaling $2,194,946. This purchase suggests a bolstering of ARK's position in the cryptocurrency exchange, hinting at a long-term bullish outlook for the sector.

In the realm of biotechnology, ARK bought 39,224 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) for $1,784,299, and 90,883 shares of Intellia Therapeutics Inc (NASDAQ:NTLA) for $1,621,352, both through the ARKK ETF. These investments underscore ARK's ongoing interest in cutting-edge gene-editing companies.

The fund also increased its holdings in Blade Air Mobility Inc (NASDAQ:BLDE), purchasing a total of 203,414 shares across the ARKQ and ARKX ETFs, valued at $701,778. This follows a pattern of consistent buying in the urban air mobility service provider over the past week.

Further diversifying its portfolio, ARK invested in 3D printing by buying 47,530 shares of 3D Systems Corp (NYSE:NYSE:DDD) for $145,441 through its ARKQ ETF, continuing a series of investments in the company.

Other notable buys included GitLab Inc (NASDAQ:GTLB) with 28,048 shares for $1,387,534, Meta Platforms Inc (NASDAQ:META) adding 2,365 shares for $1,383,004, and Recursion Pharmaceuticals Inc (NASDAQ:RXRX) with a combined purchase of 124,111 shares for $767,005 across the ARKK and ARKG ETFs.

On the sell side, ARK continued to divest from Markforged Holding Corp (NYSE:MKFG), shedding a total of 197,326 shares for $915,592. This move is part of a broader trend of selling the 3D printing company's stock in recent days. Additionally, smaller sales included Materialise NV (NASDAQ:MTLS), Rocket Lab USA Inc (NASDAQ:RKLB), Taiwan Semiconductor Manufacturing Co Ltd (NYSE:TSM), Veeva Systems Inc (NYSE:NYSE:VEEV), Vertex Pharmaceuticals Inc (NASDAQ:VRTX), and a minor sale of Vuzix Corp (NASDAQ:VUZI) shares.

Investors following ARK's trades may interpret these actions as a strategic rebalancing of the fund's portfolio, with a continued focus on innovation and disruptive technologies. The ongoing adjustments reflect ARK's active management approach, as they navigate market conditions and position for future growth opportunities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.